Cytomegalovirus retinitis

Area of Science:

• Ophthalmology
• Immunology
• Hematology

Background:

• Cytomegalovirus (CMV) retinitis can occur in immunocompromised individuals.
• Maintenance immunosuppressive therapy for lymphatic leukemia can increase the risk of opportunistic infections like CMV retinitis.

Observation:

• A patient with lymphatic leukemia undergoing maintenance immunosuppressive therapy developed cytomegalovirus retinitis.
• The retinitis showed signs of improvement upon discontinuation of the immunosuppressive treatment.

Findings:

• Cessation of immunosuppressive therapy led to partial improvement of CMV retinitis.
• Complete resolution of cytomegalovirus retinitis was achieved following an injection of lymphocyte dialysable transfer factor.

Implications:

• This case highlights the potential for reversing CMV retinitis by adjusting immunosuppressive therapy.
• Lymphocyte dialysable transfer factor may be a viable therapeutic option for managing CMV retinitis in specific patient populations.
• Further research is warranted to explore the efficacy and mechanisms of lymphocyte transfer factor in treating viral retinitis.